These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8885584

  • 21. Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.
    Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE, Medori R.
    Eur Child Adolesc Psychiatry; 2005 Sep; 14(6):297-304. PubMed ID: 16220213
    [Abstract] [Full Text] [Related]

  • 22. [Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD].
    Heger S, Trott GE, Meusers M, Schulz E, Rothenberger A, Rettig K, Medori R, Schreiner A, Remschmidt H, Vertreter der deutschen C-2000-045-Studiengruppe.
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):257-65. PubMed ID: 16927568
    [Abstract] [Full Text] [Related]

  • 23. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.
    Manos M, Frazier TW, Landgraf JM, Weiss M, Hodgkins P.
    Curr Med Res Opin; 2009 Dec; 25(12):3001-10. PubMed ID: 19849639
    [Abstract] [Full Text] [Related]

  • 24. Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
    Becker SP, Froehlich TE, Epstein JN.
    J Dev Behav Pediatr; 2016 Jun; 37(5):395-404. PubMed ID: 27011002
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.
    Bonnefois G, Robaey P, Barrière O, Li J, Nekka F.
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):320-331. PubMed ID: 28165318
    [Abstract] [Full Text] [Related]

  • 27. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS, Shen HY, Soong WT, Gau CS.
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):441-55. PubMed ID: 16958569
    [Abstract] [Full Text] [Related]

  • 28. Evaluating medication response in ADHD: cognitive, behavioral, and single-subject methodology.
    Hale JB, Hoeppner JA, DeWitt MB, Coury DL, Ritacco DG, Trommer B.
    J Learn Disabil; 1998 Aug; 31(6):595-607. PubMed ID: 9813958
    [Abstract] [Full Text] [Related]

  • 29. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL.
    Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
    [Abstract] [Full Text] [Related]

  • 30. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder.
    Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F.
    Can J Psychiatry; 2003 Sep; 48(8):546-54. PubMed ID: 14574830
    [Abstract] [Full Text] [Related]

  • 31. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
    Childress AC, Kollins SH, Cutler AJ, Marraffino A, Sikes CR.
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder.
    Setyawan J, Yang H, Cheng D, Cai X, Signorovitch J, Xie J, Erder MH.
    Value Health; 2015 Sep; 18(6):824-31. PubMed ID: 26409610
    [Abstract] [Full Text] [Related]

  • 35. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [Abstract] [Full Text] [Related]

  • 36. Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades.
    Ibrahim K, Donyai P.
    J Atten Disord; 2015 Jul; 19(7):551-68. PubMed ID: 25253684
    [Abstract] [Full Text] [Related]

  • 37. Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD.
    Pelham WE, Gnagy EM, Sibley MH, Kipp HL, Smith BH, Evans SW, Bukstein O.
    J Atten Disord; 2017 Jan; 21(2):129-136. PubMed ID: 23893533
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.